I. Introduction
TomoTherapy (TomoTherapy Incorporated, WI, USA) has recently released a software solution developed by Raysearch Laboratories AB (Stockholm, Sweden) called SharePlan TM . 1 The purpose of this software is to produce backup plans for patients treated with a TomoTherapy® Hi·Art® treatment system. This is to ensure continuous patient treatment 2 in case of unintended, as well as planned treatment interruption of the TomoTherapy unit, for clinics with a single machine installed alongside various C-arm linear accelerators (linacs). To create such backup intensity-modulated radiation therapy (IMRT) plans with another treatment planning system (TPS) is time consuming and the resulting plans might differ substantially from the prescribed TomoTherapy plans. SharePlan allows for an automated conversion of the TomoTherapy plans to step-and-shoot (SS) IMRT plans, as similar to the prescribed TomoTherapy plan as possible but deliverable on IMRT capable C-arm linacs.
A previous study verified that the plans generated in this novel TPS are deliverable and accurate. 3 The purpose of the present study was to evaluate the plans generated in SharePlan and how much a plan deteriorates when being converted from a TomoTherapy plan to an SS IMRT plan. The purpose was also to compare these automatically derived plans to plans generated in the clinical TPS used for IMRT planning (Oncentra® MasterPlan by Nucletron B.V., Veenendaal, The Netherlands), as this would be the way to generate backup plans in the clinic if SharePlan was not available. This work primarily consists of a Pareto front comparison between plans generated in the TomoTherapy TPS, in SharePlan, and in the clinical TPS (this uses an optimizer that is also produced by Raysearch 4, 5 ).
The goal of the optimizer in SharePlan is to produce an IMRT plan as similar as possible to the original TomoTherapy plan. It is anticipated that the plans will become more similar with an increasing number of beams and/or segments in the IMRT plan. However, since an excessive use of segments will add to treatment time and out-of-field dose, it is of interest to minimize the total number of segments. Therefore, in this work, we have also investigated how beams and segments are used most efficiently when generating IMRT-plans in SharePlan.
II. Materials and Methods

II.A. Plan comparison
Multi-objective optimization handles problems in which more than one objective function has to be optimized simultaneously, as in the case of treatment plan optimization in radiation therapy by inverse planning. The standard form for such a problem can be described as: 6 min{ F(x) | xQ }, (Eq. 1) (F(x)) = (f 1 (x), f 2 (x), …., f S (x)),
where F(x) is a vector of (objective) functions (f(x)), i.e. for S ≥ 2 (S=number of functions) and is defined over the feasible set Q.
An optimal point for problem (Eq. 1) is a point that is feasible (xQ) and minimizes F(x). A point x´ is called Pareto optimal if x´Q and there is no other
x ≠ x´ such that xQ, for which f S (x) ≤ f S (x´) for all s = 1, 2, …., S, with a strict inequality for at least one s, 1 ≤ s ≤ S. 6 This means that a plan (x´) is Pareto optimal if it is impossible to improve the plan in one aspect without worsening it in another and if it is deliverable (x´Q). In reality, it is of course seldom known whether the treatment plan resulting from the optimization routine of a commercial TPS is strictly optimal. However, if the noise-like effects originating from this uncertainty can be accepted, one may consider the pseudo optimal output as an effective property of the system, and it will have little practical consequences for comparative evaluations. Multiobjective minimum problems (Eq. 1) often have a set of solutions, i.e. a set of deliverable plans, which are (pseudo) Pareto optimal. A set of plans that are Pareto optimal forms a Pareto front. The dimensions of the front depend on how many objective functions that are involved in the optimization. A set of Pareto optimal plans optimized for two objective functions (S=2), for example target coverage and sparing of an organ at risk (OAR), makes up a two dimensional Pareto optimal front, which can easily be visualized in a two dimensional plot.
Pareto fronts can be used to compare plans generated in different TPS. 7 In this study Pareto fronts are used to compare plans generated in SharePlan to plans generated in the TomoTherapy system and plans generated in the TPS (Oncentra® MasterPlan) used for IMRT planning in our clinic (henceforth referred to as "clinical TPS"). Optimized plans were generated for three prostate cases ( Figure 1 ) and for three head and neck (H&N) cases, receiving the treatment with a simultaneously integrated boost (SIB) technique ( Figure 2 ). In the clinical TPS, plans were created with seven equiangular-spaced beams as well as 7-beam plans with GAO activated. The settings used for generating the 7-beam IMRT plans in the clinical TPS are displayed in Table 1 . These settings with seven beams are used clinically for IMRT plans at our department. The IMRT plans were made for SS delivery on an Elekta Synergy® linac (Elekta AB, Stockholm, Sweden) which uses the Elekta MLCi for beam shaping. TomoTherapy plans were made with a field width of 2.5 cm, a pitch of 0.287, and a maximum allowed modulation factor of 3.0, the settings used clinically for these cases at our department.
The three prostate cases had a prescribed dose of 50 Gy to the PTV for the prostate and the surrounding lymph nodes (the prostate treatments were boosted to 70 Gy with a subsequent brachytherapy not included in the present analysis). Table 1 ).
The plans were generated with equiangular-spaced beams in SharePlan since GAO was not available in this software. For each TomoTherapy plan four plans were generated in SharePlan with different target vs. OAR importance settings.
Plans exceeding the dose criteria to any of the OARs were also rejected in this system. To avoid any unwanted evaluation discrepancies, all of the generated plans were imported to and evaluated in the clinical TPS, regardless of what system they were generated in. Inferior plans i.e. plans that did not comprise the fronts, were rejected.
II.B. Plan comparison for plans generated in SharePlan with different number of beams
Pareto fronts were also created for 11-beam and 15-beam plans generated in SharePlan for the H&N cases ( Figure 2 ). The plan restrictions used (Table 1) were identical to the 7-beam plans except for the maximum allowed number of segments for the 15-beam plans which was increased to 150, the minimum value allowed in the software for a 15-beam plan. The plans were generated and evaluated in the same manner as described above. These fronts were compared to the fronts for the 7-beam plans generated in SharePlan as well as to the TomoTherapy fronts. This allowed for an evaluation of how much the result would improve when more beams were applied to the plans. This comparison would also show if the same level of plan quality could be reached for plans, with an increased number of beams, generated in SharePlan as for plans generated in the TomoTherapy system.
II.C. Number of beams vs. number of segments in SharePlan
TomoTherapy plans for four different patient cases were used to further study 
III. Results
III.A. Plan comparison
The evaluation demonstrated that plans made in SharePlan for the prostate cases were as good as or better than plans made in the clinical TPS and almost as good as the TomoTherapy plans ( Figure 4) . The results showed that the ability of the systems to spare the rectum while maintaining dose coverage of the target depended on the volume of overlap between PTV and rectum. The differences between the fronts were very small but seemed to be somewhat dependent on the volume of the PTV and rectum overlap. For the first prostate case (Figure 4 The plans made in SharePlan for the H&N cases were as good as, or better than, the plans made in the clinical TPS but not as good as the plans made in the TomoTherapy system (see Figure 5 ). The results showed that the capability of the systems to spare the parotid gland while maintaining dose coverage of the target depended on the volume of overlap between PTV and parotid gland. The differences between the fronts were larger for the H&N cases than for the prostate cases but the differences showed no clear overlap dependence. For the first H&N 
III.B. Plan comparison for plans generated in SharePlan with different number of beams
The results for the three H&N cases showed that an increase in number of beams improved the SharePlan Pareto front bringing it closer to the TomoTherapy front.
For the first H&N case (Figure 6 a) , which had the smallest overlap of the PTV and the parotid gland, 11 beams were sufficient. The plans were not further improved when more beams were added. For the second and third H&N case ( Figure 6 b and c) the fronts were improved with the number of beams used but the differences between the fronts for the 11-beam plans and 15-beam plans were small.
III.C. Number of beams vs. number of segments in SharePlan
The results from the beams vs. segments investigation are shown for the larynx case in Figure 7 , where the value of the objective function (VOF) is plotted for 48 treatment plans as a function of the number of beams and the number of segments per beam (i.e. the total used number of segments divided by the number of beams). As indicated by the dotted black arrows, VOF decreased with an increase in the number of beams or segments per beam, meaning that the plans converted in SharePlan approached the TomoTherapy plan. For a large total number of segments, the VOF reached a plateau, whereas the plans converted in SharePlan had converged with the TomoTherapy plan. A convergence criterion was defined as the average plus two standard deviations of the VOF on this plateau, and plotted as a solid blue line in Figure 7 . The dashed green curve shows VOFs for a total number of segments equal to 59, which was the smallest number required to reach the convergence criterion. This occurred with 15 beams, as indicated by the red circle in Figure 7 . It should be noted, that the same convergence criterion could also be reached with a smaller number of beams, although it required a larger total number of segments. The smallest number of beams needed to reach the convergence criterion was 11, for which the required number of total segments was 99. The smallest number of segments required to reach the convergence criterion was 36 for the oropharynx case. This occurred when 13 beams were used. The same convergence criterion could be reached for 11 beams, for which the required number of total segments was 55. The convergence criterion was reached for the intracranial case when 21 segments were distributed over 10 beams, minimizing the number of segments needed, or when 28 segments were distributed over 7 beams, minimizing the number of beams needed. For the prostate case the convergence criterion could be reached if at least 41 segments were used, distributed over 19 beams, or when at least 13 beams were used which required a total number of segments of 117. The results are displayed in Table 2 .
IV. Discussion
Comparison of plan quality is a complex matter. To decide if one plan is better than another often means evaluating and comparing many different parameters, the clinical importance of which is difficult to establish. In this study we have Plans generated in SharePlan appear to be similar or somewhat superior to plans generated in the clinical TPS, as the Pareto fronts for plans generated in SharePlan were situated on or below the fronts for plans generated in the clinical TPS. The reason why the SharePlan results are generally as good as or better than the results for the clinical TPS might be due to the initial estimate of the optimum. In SharePlan the initial estimate is derived directly from an optimized solution (i.e.
the TomoTherapy plan). In the clinical TPS, however, the initial estimate depends on the constraints and objectives chosen by the planner. Since the result of the optimization will depend on these parameters, the initial estimate may in this case result in a sub-optimal solution. These results were similar to what we previously obtained with a pre-clinical version of the software in 2009. 10, 11 The results for the prostate cases were very similar for plans generated in the different TPS but a difference between the systems could be seen for the cases with the largest PTV and rectum overlap. The differences between the systems for the prostate cases seemed to be PTV and rectum overlap dependent but the overlap dependency for the H&N cases was not obvious, and may be concealed by other factors. The ability of the different systems to spare the OAR depended, as one would expect, on the volume of the overlap of PTV and OAR. Plans generated for helical delivery were clearly superior to plans generated for SS delivery for two of the three H&N cases studied and somewhat superior for the other cases studied. The evaluation has only been performed for cases where GAO (as implemented in our clinical TPS) did not seem to improve the resulting plans substantially compared to plans with equiangular-spaced beams, i.e. equiangular-spaced beams seemed to be close to the optimal beam angles for these cases. Though the plan comparison has only been performed for prostate and H&N cases the results should be equivalent for other anatomical regions where GAO is of minor importance, as these rather different anatomical regions show similar behavior in our analysis. In regions where GAO is of major importance, e.g. for most treatments in the thorax region, the quality of the plans generated in SharePlan will depend on the planner's capability of choosing optimal beam angles as no automatic GAO is available in SharePlan.
The results for the three H&N cases also showed that the plans generated in SharePlan could be improved when more beams were used for plan generation (see Figure 6 ). The SharePlan converted plans became more equivalent to the TomoTherapy plans when more beams were added. For complex bilaterally treated H&N targets 15 beams resulted in more optimal plans, but for simpler cases, more than 11 beams did not further improve the results. Other studies involving plan quality comparison between IMRT plans generated for helical delivery to plans generated for SS delivery often show results similar to the results presented here, i.e. that plans generated for helical delivery often is slightly superior to plans generated for SS delivery. [12] [13] [14] [15] Studies also show that plan quality can be improved with increased number of beams but that the gain in plan quality tends to saturate when a large enough number of beams are used. 16, 17 This
is similar to what can be seen in these results for the H&N cases.
We have also investigated how the beams and segments of an IMRT plan are used most efficiently. This question, sometimes called the "how-many-beamsproblem", has been addressed before from a theoretical standpoint by several authors [18] [19] [20] [21] [22] . However, the solution has proven elusive, and a theoretical justification for selecting the proper number of beams in IMRT is still lacking. In this work, we approached the "how-many-beams-problem" from a practical pointof-view, in the specific setting of the SharePlan system. This was of course a less general approach, but in return, it allowed for the use of a realistic dose calculation model (collapsed cone) and real patient cases. Furthermore, the results have a direct clinical applicability, as it can be used when converting TomoTherapy plans to fixed-beam IMRT plans in SharePlan. To what extent the results from this study may also be applicable to IMRT planning in general remains to be investigated. For this particular investigation, the TomoTherapy plan was conceived as a gold standard, as this was the goal of the optimizer in SharePlan, but it should be noted that this does not necessarily mean that the TomoTherapy plan is always better in a clinical context. For the cases investigated here, the results (as exemplified by the larynx case in Figure 7) clearly demonstrated that above a certain limit, the addition of further segments did not improve the result. The number of IMRT beams required to converge with the original TomoTherapy plan was at minimum between 7 and 13. By adding more beams, however, the total number of segments could be minimized, representing a reduction by as much as 25% to 65% for the investigated cases.
Although this evidently required a fairly large number of beams, between 10 and 19, this may be a significant gain in terms of shorter delivery time and a lower out-of-field dose contribution. The results from our practical approach to the "how-many-beams-problem" are in agreement with the theoretical results presented by Bortfeld, 18 saying that 10-20 beams should be used for SS IMRT.
These results also correlate well with the Pareto front evaluation of the H&N cases which showed that 11 and 15-beam plans where more optimal than 7-beam plans. IMRT plans can only be generated for SS delivery in SharePlan, but these results also indicate that volumetric arc therapy would be useful, if and when it becomes available as a delivery technique for plans generated in SharePlan.
The quality of the plans generated with SharePlan depended on the quality of the plans generated with the TomoTherapy system. Since the plan generation process in SharePlan is basically automated there is an inherent inability for the planner to influence the resulting plan. This might result in plans not fulfilling all dosevolume criteria for all OARs or in unwanted hot-spots. These problems can be handled in three different ways. If the problem is minor an isocenter shift might suffice, for larger issues one can change the gantry angles used, or one can increase the number of beams.
The results achieved in this study indicate that TomoTherapy combined with Shareplan could be used instead of conventional IMRT planning. This would be useful if it is unclear whether the patient will benefit from treatment with the TomoTherapy unit rather than with SS IMRT at a C-arm linac. A TomoTherapy plan as well as a SS-IMRT plan could be created and compared without much extra work. This would enable a more optimal use of the TomoTherapy unit in clinics with a mix of treatment modalities and units. This might also be timesaving way of IMRT planning as Shareplan does not require a "perfect" TomoTherapy plan to generate a "near perfect" SS IMRT plan.
V. Conclusions
This study showed (using Pareto front evaluation) that the plans generated in SharePlan were comparable to plans generated in our clinical TPS. The evaluation showed that the plans generated in SharePlan could be improved whit the use of SharePlan may also be useful to optimize the use of SS and helical delivery techniques for clinics with both techniques available. 
Plan restrictions Settings
Energy (MV) 6
Delivery technique
Step-and-shoot
Number of beams 7,11/15
Maximum allowed number of segments 120/150
Minimum number of Monitor Units/segment 3 Minimum segment area (cm 2 ) 5
Minimum equivalent square (cm 2 ) 5
Leaf jaw overlap (cm) 0 
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